Congratulations to Dr. Fumio Takei (Takei Lab) and Dr. Marco Marra (Marra Lab), for receiving a Canadian Institutes of Health Research (CIHR) Project Grant Program for the project titled, “Innate lymphoid cells in hepatitis and liver fibrosis.”

Congratulations to Dr. Faezeh Borzooee (Kuchenbauer Lab), for receiving the Michael Smith Health Research BC Research Trainee award 2023 for the work titled, "Targeting APOBEC3 enzymes as novel metabolic regulators in multiple myeloma."

Congratulations to Dr. Athena Phoa for receiving the Michael Smith Health Research BC Research Trainee award 2023 for the work titled, "Restoration of miR-185 in combination with BCR-ABL downregulation by non-viral delivery of siRNA with lipomeric carriers and lipid nanoparticles sensitizes drug resistant cells to TKIs."

Afsaneh Panahi, graduate student at the Kuchenbauer Lab has been awarded an International Myeloma Society (IMS) Young Investigator Award for Exemplary Abstract, for the abstract titled, “Dysregulated APOBEC3B promotes cell proliferation and DNA damage in multiple myeloma."

BC Cancer's Dr. Florian Kuchenbauer and Dr. François Bénard, in collaboration with TRIUMF Innovations and led by Dr. Robert Britton from Simon Fraser University, have secured a grant from the Centre for Probe Development and Commercialization (CPDC)  to conduct ground-breaking research in cancer imaging.

Kwangjin Park (Hoodless Lab) has been awarded the Canadian Institutes of Health Research 2022 Postdoctoral Fellowship Award for the project titled, "Roles of the Lysine Methyl Transferase (KMT) 2D in hepatocyte cell identity and hepatocellular carcinoma (HCC) progression." Read the announcement here.

BC Cancer scientist Dr. Ly Vu is one of 11 recipients of A Grant of Her Own: The Women Scientists Innovation Award for Cancer Research. This new granting program, developed by the V Foundation for Cancer Research, sees $8 million in funding invested in cancer research being led by women scientists. Dr.

A recent study conducted by researchers at BC Cancer has shed light on the cause behind the different outcomes of patients with diffuse large B-cell lymphoma (DLBCL) who experience a relapse of their disease. The study, led by Dr. Laura Hilton, staff scientist at BC Cancer’s Centre for Lymphoid Cancer (CLC), and Dr. David Scott, clinical director of the CLC, aimed to understand the molecular characteristics of the initial diagnostic and relapse tumour samples of patients with DLBCL.

Dr. Carol Chen is dedicated to understanding the complexities and finding innovative solutions to high-grade gliomas (HGGs); a particularly aggressive form of brain cancer affecting children and young adults. The new BC Cancer scientist, who joined the Terry Fox Laboratory in 2023, is focused on understanding how mutations in certain proteins, called histones or histone-modifying enzymes, contribute to the development of HGGs.

Congratulations to Dr. Peter Lansdorp (Lansdorp Lab), along with Dr. Kasmintan Schrader and Dr. Steven Jones, for being awarded a Canadian Institutes of Health Research (CIHR) Project Grant for the project titled “Parent-Of-Origin-Aware Genomic Analysis in Hereditary Cancer."